Items where Author is "Lees, P"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 125.

Article

Concordet, D and Gandia, P and Montastruc, J-L and Bousquet-Mélou, A and Lees, P and Ferran, A A and Toutain, P-L (2019) Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? Clinical Pharmacokinetics.

Toutain, P-L and Sidhu, P K and Lees, P and Rassouli, A and Pelligand, L (2019) VetCAST method for determination of the pharmacokineticpharmacodynamic cut-off values of a long-acting formulation of florfenicol to support clinical breakpoints for florfenicol Antimicrobial Susceptibility Testing in cattle. Frontiers in Microbiology, 10 (1310).

Pelligand, L and Lees, P and Sidhu, P K and Toutain, P-L (2019) Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and in silico Dose Fractionation for Calf Respiratory Pathogens. Frontiers in Microbiology, 10.

Concordet, D and Gandia, P and Montastruc, J L and Bousquet-Mélou, A and Lees, P and Ferran, A and Toutain, P L (2019) Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?". Clinical Pharmacokinetics.

Concordet, D and Gandia, P and Montastruc, J L and Bousquet-Mélou, A and Lees, P and Ferran, A and Toutain, P L (2019) Authors' Reply to Nicolas: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?". Clinical Pharmacokinetics.

Concordet, D and Gandia, P and Montastruc, J L and Bousquet-Mélou, A and Lees, P and Ferran, A and Toutain, P L (2019) Levothyrox® new and old formulations: are they switchable for millions of patients? Clinical Pharmacokinetics.

Mead, A and Lees, P and Mitchell, J and Rycroft, A and Standing, J F and Toutain, P L and Pelligand, L (2019) Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 42 (1). pp. 52-59.

Whitehead, M L and Chambers, D and Lees, P and Toutain, P-L (2019) The UK veterinary profession’s response to antimicrobial resistance: A brief review. Regulatory Rapporteur, 16 (3). pp. 10-12.

Whitehead, M L and Lees, P and Toutain, P L (2018) Veterinary homeopathy regulation in the UK – a cause for concern. Regulatory Rapporteur, 15 (11). (In Press)

Lees, P and Potter, T and Pelligand, L and Toutain, P L (2018) Pharmacokinetic–pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 41 (1). pp. 28-38.

Whitehead, M and Chambers, D and Lees, P and Pelligand, L and Toutain, P L and Whiting, M (2017) The authors of ‘Comparison of veterinary drugs and veterinary homeopathy: part 1 and 2’, respond. VETERINARY RECORD, 181. pp. 457-458.

Lees, P and Chambers, D and Pelligand, L and Toutain, P L and Whiting, M and Whitehead, M L (2017) Comparison of veterinary drugs and veterinary homeopathy: part 2. VETERINARY RECORD, 181. pp. 198-207.

Lees, P and Chambers, D and Pelligand, L and Toutain, P L and Whiting, M and Whitehead, M L (2017) Comparison of veterinary drugs and veterinary homeopathy: part 1. VETERINARY RECORD, 181 (7). pp. 170-176.

Dorey, L and Pelligand, L and Lees, P (2017) Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling. BMC Veterinary Research, 13 (209).

Lees, P and Illambas, J and Potter, T J and Pelligand, L and Rycroft, A and Toutain, P L (2017) A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 40 (5). pp. 429-438.

Dorey, L and Lees, P (2017) Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens. BMC Veterinary Research, 13 (192).

Dorey, L and Pelligand, L and Cheng, Z R and Lees, P (2017) Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. PLoS One, 12 (5). e0177568.

Dorey, L and Hobson, S and Lees, P (2017) Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. RESEARCH IN VETERINARY SCIENCE, 111. pp. 93-98.

Dorey, L and Hobson, S and Lees, P (2017) Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media. RESEARCH IN VETERINARY SCIENCE, 111. pp. 43-48.

Dorey, L and Hobson, S and Lees, P (2017) What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida? JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 40 (5). pp. 517-529.

Dorey, L and Pelligand, L and Cheng, Z R and Lees, P (2017) Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 40 (5). pp. 505-516.

Toutain, P L and Potter, T J and Pelligand, L and Lacroix, M and Illambas, J and Lees, P (2017) Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 40 (1). pp. 16-27.

Lees, P and Illambas, J and Pelligand, L and Toutain, P L (2016) Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against mannheimia haemolytica and pasteurella multocida. VETERINARY JOURNAL, 218. pp. 60-64.

Dorey, L and Hobson, S and Lees, P (2016) Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology. VETERINARY JOURNAL, 218. pp. 65-70.

Toutain, P L and Ferran, A A and Bousquet-Mélou, A and Pelligand, L and Lees, P (2016) Veterinary Medicine Needs New Green Antimicrobial Drugs. Frontiers in Microbiology, 7. p. 1196.

Pelligand, L and Suemanotham, N and King, J N and Seewald, W and Syme, H M and Smith, K C and Lees, P and Elliott, J (2015) Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney. BMC Veterinary Research, 11 (296).

Lees, P and Pelligand, L and Illambas, J and Potter, T J and Lacroix, M and Rycroft, A N and Toutain, P L (2015) Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 38 (5). pp. 457-70.

Lees, P and Pelligand, L and Ferran, A and Bousquet-Mélou, A and Toutain, P L (2015) Application of pharmacological principles to dosage design of antimicrobial drugs. Pharmacology matters, 8 (1). p. 22.

Toutain, P L and Pelligand, L and Potter, T and Lacroix, M and Illambas, J and Lees, P (2015) Demonstration of applicability of PK/PD concepts to determine a dosage regimen for tulathromycin in the calf. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 38. pp. 13-14.

Lees, P and Pelligand, L and Elliott, J and Toutain, P L and Michels, G and Stegemann, M (2015) Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 38 (1). pp. 1-14.

Toutain, P L and Bousquet-Mélou, A and Ferran, A and Pelligand, L and Lees, P (2015) Veterinary medicine needs new and innovative green antimicrobial drugs. Pharmacology matters, 8 (1). p. 20.

Pelligand, L and King, J N and Hormazabal, V and Toutain, P L and Elliott, J and Lees, P (2014) Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 37 (4). pp. 354-366.

Sidhu, P and Rassouli, A and Illambas, J and Potter, T and Pelligand, L and Rycroft, A N and Lees, P (2014) Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 37 (3). pp. 231-42.

Brentnall, C and Cheng, Z R and McKellar, Q A and Lees, P (2013) Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36 (4). pp. 320-328.

Lees, P and Cheng, Z R and Keefe, T J and Weich, E and Bryd, J and Cedergren, R and Cozzi, E (2013) Bioequivalence in dogs of a meloxicam formulation administered as a transmucosal oral mist with an orally administered pioneer suspension product. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36 (1). pp. 78-84.

King, J N and Jung, M and Maurer, M P and Schmid, V B and Seewald, W and Lees, P (2013) Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats. AMERICAN JOURNAL OF VETERINARY RESEARCH, 74 (3). pp. 465-472.

Pelligand, L and Lees, P (2013) Monitoring and treating chronic pain in cats: Bring on the challenge! VETERINARY JOURNAL, 196 (3). pp. 275-276.

Illambas, J and Potter, T and Sidhu, P and Rycroft, A N and Cheng, Z R and Lees, P (2013) Pharmacodynamics of florfenicol for calf pneumonia pathogens. VETERINARY RECORD, 172 (13).

Illambas, J and Potter, T and Cheng, Z R and Rycroft, A N and Fishwick, J C and Lees, P (2013) Pharmacodynamics of marbofloxacin for calf pneumonia pathogens. RESEARCH IN VETERINARY SCIENCE, 94 (3). pp. 675-681.

Potter, T J and Illambas, J and Pelligand, L and Rycroft, A N and Lees, P (2013) Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida. VETERINARY JOURNAL, 195 (1). pp. 53-8.

Brentnall, C and Cheng, Z R and McKellar, Q A and Lees, P (2013) Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves. RESEARCH IN VETERINARY SCIENCE, 94 (3). pp. 687-694.

Lees, P (2013) Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36 (3). pp. 209-221.

Lees, P and Toutain, P L (2013) Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses. VETERINARY JOURNAL, 196 (3). pp. 294-303.

Lees, P and Toutain, P L (2013) Phenylbutazone in horses and man: Properties relevant to safety of humans consuming horse meat containing phenylbutazone and its metabolites. EQUINE VETERINARY EDUCATION, 25 (11). pp. 545-549.

Lees, P and Fink-Gremmels, J and Toutain, P L (2013) Veterinary pharmacology: history, current status and future prospects. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36 (2). pp. 105-115.

Pelligand, L and House, A K and Summers, B A and Hatzis, A and Tivers, M S and Elliott, J and Lees, P (2012) Development and validation of a tissue cage model of acute inflammation in the cat. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 35 (3). pp. 239-248.

Hunter, R P and Lees, P and Concordet, D and Toutain, P L (2012) Establishing bioequivalence of veterinary premixes (Type A medicated articles). JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 35. pp. 53-63.

Brentnall, C and Cheng, Z R and McKellar, Q A and Lees, P (2012) Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves. VETERINARY RECORD, 171 (11). 273-U59.

Pelligand, L and King, J N and Toutain, P L and Elliott, J and Lees, P (2012) Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 35 (1). pp. 19-32.

Lees, P and Cheng, Z R and Chambers, M and Speirs, G and Hennessy, D and Abbott, E M (2012) Pharmacokinetics and bioequivalence in the pig of two ivermectin feed formulations. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36 (4). pp. 350-357.

Lees, P and Hunter, R P and Reeves, P T and Toutain, P L (2012) Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 35. pp. 17-30.

Brentnall, C and Cheng, Z R and McKellar, Q A and Lees, P (2012) Potency and selectivity of carprofen enantiomers for inhibition of bovine cyclooxygenase in whole blood assays. RESEARCH IN VETERINARY SCIENCE, 93 (3). pp. 1387-92.

King, J N and Hotz, R and Reagan, E L and Roth, D R and Seewald, W and Lees, P (2012) Safety of oral robenacoxib in the cat. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 35 (3). pp. 290-300.

Lees, P and Toutain, P L (2012) The role of pharmacokinetics in veterinary drug residues. DRUG TESTING AND ANALYSIS, 4. pp. 34-39.

Potter, T J and Lees, P (2011) Antimicrobial Resistance in Farm Animals: Origins, Mechanisms, Avoidance, Implications. Royal Agricultural Society of England Journal, 172.

Pelligand, L and Lees, P and Elliott, J (2011) Development and validation of a timed urinary collection system for use in the cat. Laboratory Animals, 45 (3). pp. 196-203.

Sidhu, P K and Landoni, M F and Aliabadi, M H S and Toutain, P L and Lees, P (2011) Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 34 (4). pp. 376-387.

Lees, P (2011) Pharmacology and/or homeopathy. VETERINARY RECORD, 169 (14). p. 368.

King, J N and Arnaud, J P and Goldenthal, E I and Gruet, P and Jung, M and Seewald, W and Lees, P (2011) Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 34 (3). pp. 298-311.

Briston, L and Dudhia, J and Lees, P (2010) Age-related differences in prostaglandin E-2 synthesis by equine cartilage explants and synoviocytes. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 33 (3). pp. 268-276.

Schmid, V B and Spreng, D E and Seewald, W and Jung, M and Lees, P and King, J N (2010) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 33 (2). pp. 118-131.

Guyonnet, J and Manco, B and Baduel, L and Kaltsatos, V and Aliabadi, M H S and Lees, P (2010) Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of GIT disease in pigs. RESEARCH IN VETERINARY SCIENCE, 88 (2). pp. 307-314.

Schmid, V B and Seewald, W and Lees, P and King, J N (2010) In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 33 (5). pp. 444-452.

King, J N and Rudaz, C and Borer, L and Jung, M and Seewald, W and Lees, P (2010) In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: A comparative study. RESEARCH IN VETERINARY SCIENCE, 88 (3). pp. 497-506.

Sidhu, P K and Landoni, M F and Aliabadi, F S and Lees, P (2010) PK-PD integration and modeling of marbofloxacin in sheep. RESEARCH IN VETERINARY SCIENCE, 88 (1). pp. 134-141.

Sidhu, P K and Landoni, M F and Aliabadi, F S and Lees, P (2010) Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats. VETERINARY JOURNAL, 184 (2). pp. 219-229.

Jung, M and Lees, P and Seewald, W and King, J N (2009) Analytical determination and pharmacokinetics of robenacoxib in the dog. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32 (1). pp. 41-48.

Giraudel, J M and Toutain, P L and King, J N and Lees, P (2009) Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32 (1). pp. 31-40.

King, J N and Rudaz, C and Borer, L and Jung, M and Seewald, W and Lees, P (2009) Evaluation of robenacoxib as a cyclooxygenase inhibitor in the dog: a comparative study. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32. p. 222.

Schmid, V B and King, J N and Seewald, W and Lees, P (2009) IN VITRO AND EX VIVO INHIBITION OF COX ISOFORMS BY ROBENACOXIB IN THE CAT: A COMPARATIVE STUDY. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32. p. 228.

King, J N and Dawson, J and Esser, R E and Fujimoto, R and Kimble, E F and Maniara, W and Marshall, P J and O'Byrne, L and Quadros, E and Toutain, P L and Lees, P (2009) Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32 (1). pp. 1-17.

Giraudel, J M and King, J N and Jeunesse, E C and Lees, P and Toutain, P L (2009) Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 32 (1). pp. 18-30.

Sidhu, P K and Landoni, M F and Lees, P (2006) Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats. RESEARCH IN VETERINARY SCIENCE, 80 (1). pp. 79-90.

Giraudel, J M and Diquelou, A and Lees, P and Toutain, P L (2005) Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 28 (3). pp. 275-285.

Giraudel, J M and Toutain, P L and Lees, P (2005) Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats. AMERICAN JOURNAL OF VETERINARY RESEARCH, 66 (4). pp. 700-709.

Sidhu, PK and Landoni, M F and Lees, P (2005) Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 28 (1). pp. 109-119.

Giraudel, J M and Diquelou, A and Laroute, V and Lees, P and Toutain, P L (2005) Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat. BRITISH JOURNAL OF PHARMACOLOGY, 146 (5). pp. 642-653.

Dunnett, M and Richardson, D W and Lees, P (2004) Detection of enrofloxacin and its metabolite ciprofloxacin in equine hair. RESEARCH IN VETERINARY SCIENCE, 77 (2). pp. 143-151.

Dunnett, M and Lees, P (2004) Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: a pilot study. EQUINE VETERINARY JOURNAL, 36 (2). pp. 113-117.

Dunnett, M and Lees, P (2004) Retrospective detection and deposition profiles of potentiated sulphonamides in equine hair by liquid chromatography. CHROMATOGRAPHIA, 59 (S). S69-S78.

Wilmink, J M and Veenman, J N and van den Boom, R and Rutten, V P M G and Niewold, T A and Broekhuisen-Davies, J M and Lees, P and Armstrong, S and van Weeren, P R and Barneveld, A (2003) Differences in polymorphonucleocyte function and local inflammatory response between horses and ponies. EQUINE VETERINARY JOURNAL, 35 (6). pp. 561-569.

Rickards, K J and Page, C P and Lees, P and Gettinby, G and Cunningham, F M (2003) In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 26 (2). pp. 123-130.

Lees, P and Taylor, P M and Landoni, F M and Arifah, A K and Waters, C (2003) Ketoprofen in the cat: Pharmacodynamics and chiral pharmacokinetics. VETERINARY JOURNAL, 165 (1). pp. 21-35.

Arifah, A K and Landoni, M F and Lees, P (2003) Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 26 (2). pp. 139-150.

Aliabadi, F S and Lees, P (2003) Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. RESEARCH IN VETERINARY SCIENCE, 74 (3). pp. 247-259.

Aliabadi, F S and Landoni, M F and Lees, P (2003) Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47 (2). pp. 626-635.

Aliabadi, F S and Ali, B H and Landoni, M F and Lees, P (2003) Pharmacokinetics and PKPD modelling of danofloxacin in camel serum and tissue cage fluids. VETERINARY JOURNAL, 165 (2). pp. 104-118.

Sidhu, P and Aliabadi, F S and Andrews, M and Lees, P (2003) Tissue chamber model of acute inflammation in farm animal species. RESEARCH IN VETERINARY SCIENCE, 74 (1). pp. 67-77.

Dunnett, M and Lees, P (2003) Trace element, toxin and drug elimination in hair with particular reference to the horse. RESEARCH IN VETERINARY SCIENCE, 75 (2). pp. 89-101.

Dean, M F and Lee, Y W and Dastjerdi, A M and Lees, P (2003) The effect of link peptide on proteoglycan synthesis in equine articular cartilage. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1622 (3). pp. 161-168.

Marr, K A and Lees, P and Cunningham, F M (2002) Antigen challenge increases adherence of circulating neutrophils in horses with chronic obstructive pulmonary disease. EQUINE VETERINARY JOURNAL, 34 (1). pp. 65-70.

Frean, S P and Cambridge, H and Lees, P (2002) Effects of anti-arthritic drugs on proteoglycan synthesis by equine cartilage. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 25 (4). pp. 289-298.

Armstrong, S and Lees, P (2002) Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-alpha by equine chondrocytes and synoviocytes. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 25 (2). pp. 145-153.

Lees, P and Aliabadi, F S and Landoni, M F (2002) Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 25 (6). pp. 433-448.

Arifah, A K and Lees, P (2002) Pharmacodynamics and pharmacokinetics of phenylbutazone in calves. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 25 (4). pp. 299-309.

Aliabadi, F S and Lees, P (2002) Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 25 (3). pp. 161-174.

Dunnett, M and Littleford, A and Lees, P (2002) Phenobarbitone concentrations in the hair, saliva and plasma of eight epileptic dogs. VETERINARY RECORD, 150 (23). pp. 718-724.

Rickards, K J and Page, C P and Lees, P and Cunningham, F M (2001) Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 24 (4). pp. 275-281.

Arifah, A K and Landoni, M F and Frean, S P and Lees, P (2001) Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. AMERICAN JOURNAL OF VETERINARY RESEARCH, 62 (1). pp. 77-86.

Aliabadi, F S and Lees, P (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. AMERICAN JOURNAL OF VETERINARY RESEARCH, 62 (12). pp. 1979-1989.

Book Section

Cunningham, F M and Elliott, J and Lees, P (2010) Comparative and Veterinary Pharmacology Introduction. In: UNSPECIFIED UNSPECIFIED, pp. 3-17.

Cunningham, F M and Elliott, J and Lees, P (2010) From Materia Medica to veterinary pharmacology and therapeutics. Introduction. In: UNSPECIFIED UNSPECIFIED, pp. 3-17.

Conference or Workshop Item

Dorey, L and Pelligand, L and Illambas, J and Potter, T and Toutain, P L and Lees, P (2015) PK/PD MODELLING OF OXYTETRACYCLINE FOR PNEUMONIA PATHOGENS. In: UNSPECIFIED.

Potter, T J and Illambas, J and Rycroft, A N and Toutain, P L and Lacroix, MZ and Lees, P (2012) INTEGRATION OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR TULATHROMYCIN IN HEALTHY AND PNEUMONIC CALVES. In: UNSPECIFIED.

Pelligand, L and King, J N and Hormazabal, V and Toutain, P L and Elliott, J and Lees, P (2012) PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT. In: UNSPECIFIED.

King, J N and Jung, M and Maurer, M P and Schmid, V B and Seewald, W and Lees, P (2012) PHARMACOKINETICS OF ROBENACOXIB IN THE CAT. In: UNSPECIFIED.

Potter, T J and Illambas, J and Sidhu, P K and Rassouli, A and Rycroft, A N and Lees, P (2010) INTEGRATION OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR FLORFENICOL IN CALVES. In: UNSPECIFIED.

Schmid, V B and Spreng, D E and Seewald, W and Jung, M and Lees, P and King, J N (2009) ANALGESIC AND ANTI-INFLAMMATORY ACTIONS OF ROBENACOXIB IN ACUTE JOINT INFLAMMATION IN THE DOG. In: UNSPECIFIED.

Pelligand, L and King, J N and Toutain, P L and Lees, P (2009) IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION. In: UNSPECIFIED.

Potter, T J and Illambas, J and Rycroft, A N and Lees, P (2009) INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR MARBOFLOXACIN IN CALVES. In: UNSPECIFIED.

Potter, T J and Illambas, J and Rycroft, A N and Brentnall, C and McKellar, Q A and Lees, P (2009) INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR OXYTETRACYCLINE IN CALVES. In: UNSPECIFIED.

Illambas, J and Potter, T and Rycroft, A N and Lees, P (2009) PHARMACODYNAMICS OF AMOXICILLIN IN VITRO AND EX VIVO AGAINST CALF RESPIRATORY PATHOGENS. In: UNSPECIFIED.

Illambas, J and Potter, T and Rycroft, A N and Lees, P (2009) PHARMACODYNAMICS OF TULATHROMYCIN IN VITRO AND EX VIVO AGAINST CALF PATHOGENS. In: UNSPECIFIED.

Sidhu, P K and Illambas, J and Potter, T J and Rycroft, A N and Lees, P (2009) PHARMACOKINETICS AND PHARMACODYNAMICS OF FLORFENICOL IN CALVES. In: UNSPECIFIED.

Lees, P and Alexander-Bowman, S and Hummel, B and Kubiak, T and Michels, G and Krautmann, M and Cox, S and Toutain, P L and Stegemann, M (2009) PHARMACOKINETICS AND PHARMACODYNAMICS OF MAVACOXIB IN THE DOG. In: UNSPECIFIED.

Lees, P and Giraudel, J and Toutain, P L and Pelligand, L and King, J N (2009) PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS. In: UNSPECIFIED.

Sidhu, P K and Toutain, P L and Aliabadi, F S and Landoni, M F and Lees, P (2009) PK-PD MODELLING OF MARBOFLOXACIN IN THE PRESENCE AND ABSENCE OF TOLFENAMIC ACID IN TWO RUMINANT SPECIES. In: UNSPECIFIED.

Toutain, P L and Lees, P (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. In: UNSPECIFIED.

Lees, P and Giraudel, J and Landoni, M F and Toutain, P L (2004) PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology. In: UNSPECIFIED.

Lees, P and Landoni, M F and Giraudel, J and Toutain, P L (2004) Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. In: UNSPECIFIED.

Lees, P and Cunningham, F M and Elliott, J (2004) Principles of pharmacodynamics and their applications in veterinary pharmacology. In: UNSPECIFIED.

Lees, P and Aliabadi, F S (2002) Rational dosing of antimicrobial drugs: animals versus humans. In: UNSPECIFIED.

Book

Dunnett, M and Tracy, S and Lees, P (2006) Equine hair analysis: a non-invasive technique for identifying exposure to drugs and toxins. UNSPECIFIED, pp. 29-49.

Other

Potter, T J and Illambas, J and Pelligand, L and Rycroft, A N and Lees, P (2013) PHARMACOKINETIC AND PHARMACODYNAMIC INTEGRATION AND MODELING OF MARBOFLOXACIN IN CALVES FOR MANNHEIMIA HAEMOLYTICA AND PASTEURELLA MULTOCIDA (VOL 195, PG 53, 2013) - CORRECTION. UNSPECIFIED.

Pridmore, A and Burch, D and Lees, P (2011) Determination of minimum inhibitory and minimum bactericidal concentrations of tiamulin against field isolates of Actinobacillus pleuropneumoniae. UNSPECIFIED.

This list was generated on Fri Dec 6 07:32:06 2019 GMT.